CYBEROPTICS CORP

2021 Q4 Form 10-Q Financial Statement

#000089710121000885 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.01M $17.92M $14.21M
YoY Change 27.19% 26.08% -10.63%
Cash & Equivalents $13.68M $11.01M $5.665M
Short-Term Investments $7.327M $6.911M $8.550M
Other Short-Term Assets $864.0K $1.203M $1.683M
YoY Change -2.92% -28.52% -7.48%
Inventory $27.60M $20.68M $21.29M
Prepaid Expenses $808.0K $1.092M $685.0K
Receivables $19.82M $26.91M $18.17M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $70.11M $67.80M $56.03M
YoY Change 32.02% 20.99% 18.22%
LONG-TERM ASSETS
Property, Plant & Equipment $3.174M $3.512M $3.237M
YoY Change -1.89% 8.5% -8.71%
Goodwill $1.366M $1.366M $1.366M
YoY Change 0.0% 0.0% 0.0%
Intangibles $375.0K $381.0K $286.0K
YoY Change 15.38% 33.22% -3.05%
Long-Term Investments $17.28M $15.59M $13.70M
YoY Change 23.0% 13.82% 45.9%
Other Assets $3.668M $3.761M $4.660M
YoY Change -20.26% -19.29% 1771.49%
Total Long-Term Assets $27.92M $27.01M $26.49M
YoY Change 4.89% 1.95% 19.82%
TOTAL ASSETS
Total Short-Term Assets $70.11M $67.80M $56.03M
Total Long-Term Assets $27.92M $27.01M $26.49M
Total Assets $98.02M $94.80M $82.53M
YoY Change 22.96% 14.88% 18.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.28M $10.66M $10.05M
YoY Change 100.76% 6.08% 103.26%
Accrued Expenses $4.418M $4.353M $3.685M
YoY Change 13.49% 18.13% 56.81%
Deferred Revenue $599.0K $751.0K $758.0K
YoY Change -27.22% -0.92% 43.56%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.16M $16.62M $15.26M
YoY Change 51.66% 8.86% 79.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $177.0K $172.0K $150.0K
YoY Change 32.09% 14.67% -7.41%
Total Long-Term Liabilities $177.0K $172.0K $150.0K
YoY Change 32.09% 14.67% -7.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.16M $16.62M $15.26M
Total Long-Term Liabilities $177.0K $172.0K $150.0K
Total Liabilities $18.92M $19.53M $18.99M
YoY Change 33.32% 2.84% 58.33%
SHAREHOLDERS EQUITY
Retained Earnings $41.56M
YoY Change 44.25%
Common Stock $39.05M $38.63M $37.65M
YoY Change 3.27% 2.6% 3.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $79.11M $75.28M $63.54M
YoY Change
Total Liabilities & Shareholders Equity $98.02M $94.80M $82.53M
YoY Change 22.96% 14.88% 18.73%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
0-16577
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
dei Entity Shell Company
EntityShellCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0000768411
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
CYBEROPTICS CORP
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1472057
dei Entity Address Address Line1
EntityAddressAddressLine1
5900 Golden Hills Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
MINNEAPOLIS
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55416
dei City Area Code
CityAreaCode
(763)
dei Local Phone Number
LocalPhoneNumber
542-5000
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
CYBE 
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7355549 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11005000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8399000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6911000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8121000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
475000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
302000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26908000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14735000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
20677000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
20271000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1092000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
686000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1203000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
890000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
67796000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
53102000 USD
CY2021Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
15593000 USD
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
14052000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3512000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3235000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
381000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
325000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
1366000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1366000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2186000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2621000 USD
CY2021Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
209000 USD
CY2020Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
418000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3761000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4597000 USD
CY2020Q4 us-gaap Assets
Assets
79716000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10662000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5118000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
751000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
823000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3893000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
850000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
819000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16616000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10653000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
172000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2581000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3244000 USD
CY2021Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
157000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
157000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
19526000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
14188000 USD
CY2021Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7355549 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7355549 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7294617 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7294617 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
38628000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
37817000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1511000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1102000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28813000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
75278000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
65528000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
94804000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79716000 USD
CY2021Q3 us-gaap Revenues
Revenues
27762000 USD
us-gaap Revenues
Revenues
70698000 USD
us-gaap Revenues
Revenues
53245000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
15033000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
12125000 USD
us-gaap Cost Of Revenue
CostOfRevenue
38481000 USD
us-gaap Cost Of Revenue
CostOfRevenue
29953000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
8695000 USD
us-gaap Gross Profit
GrossProfit
32217000 USD
us-gaap Gross Profit
GrossProfit
23292000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2648000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2403000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8162000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6980000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4912000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4082000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13495000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11900000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5169000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2210000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-156000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
203000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-190000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
178000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-441000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
10560000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4412000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
143000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
203000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
326000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5312000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2208000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10763000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4738000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
409000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1415000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
462000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
4798000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1799000 USD
us-gaap Net Income Loss
NetIncomeLoss
9348000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7324000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7240000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7305000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7198000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7519000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7520000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7445000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
4798000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1799000 USD
us-gaap Net Income Loss
NetIncomeLoss
9348000 USD
us-gaap Net Income Loss
NetIncomeLoss
4276000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-159000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
236000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-285000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-210000 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-31000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-58000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-7000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-6000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-12000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-32000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
43000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-184000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
190000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-409000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
9000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-50000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4614000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8939000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4226000 USD
us-gaap Net Income Loss
NetIncomeLoss
9348000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1895000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1899000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
435000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
384000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
244000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
43000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
865000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
289000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
45000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
181000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
999000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
863000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-23000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12208000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1721000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1142000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
663000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
785000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5594000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3060000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-45000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
208000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
487000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1120000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-632000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-616000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5118000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2482000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
8682000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9016000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
225000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
10637000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1570000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1049000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
208000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
115000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2333000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2785000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
292000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
322000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
727000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
420000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
247000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
224000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-188000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
126000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2606000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-171000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8399000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5836000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11005000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5665000 USD
CY2021Q3 us-gaap Revenues
Revenues
27762000 USD
CY2021Q3 cybe Percentage Of Revenue Performance Obligations
PercentageOfRevenuePerformanceObligations
1.000 pure
CY2020Q3 us-gaap Revenues
Revenues
20820000 USD
CY2020Q3 cybe Percentage Of Revenue Performance Obligations
PercentageOfRevenuePerformanceObligations
1.000 pure
us-gaap Revenues
Revenues
70698000 USD
cybe Percentage Of Revenue Performance Obligations
PercentageOfRevenuePerformanceObligations
1.000 pure
us-gaap Revenues
Revenues
53245000 USD
cybe Percentage Of Revenue Performance Obligations
PercentageOfRevenuePerformanceObligations
1.000 pure
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
22000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
453000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
567000 USD
CY2021Q3 cybe Contract With Customer Liability Deferred Warranty Revenue
ContractWithCustomerLiabilityDeferredWarrantyRevenue
413000 USD
CY2020Q4 cybe Contract With Customer Liability Deferred Warranty Revenue
ContractWithCustomerLiabilityDeferredWarrantyRevenue
344000 USD
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
257000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
287000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
347000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
106000 USD
CY2020Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
86000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
225000 USD
CY2021Q3 cybe Contract With Customer Liability And Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized
377000 USD
CY2020Q3 cybe Contract With Customer Liability And Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized
373000 USD
cybe Contract With Customer Liability And Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized
572000 USD
cybe Contract With Customer Liability And Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized
375000 USD
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
7456000 USD
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
11000 USD
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
226000 USD
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
741000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
cybe Maximum Maturity Of Debt Securities
MaximumMaturityOfDebtSecurities
P5Y
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
73000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
229000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
225000 USD
CY2021Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2021Q3 cybe Marketable Securities Classified As Cash Equivalents Cost
MarketableSecuritiesClassifiedAsCashEquivalentsCost
6000000.0 USD
CY2020Q4 cybe Marketable Securities Classified As Cash Equivalents Cost
MarketableSecuritiesClassifiedAsCashEquivalentsCost
1300000 USD
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2021Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
22504000 USD
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
22173000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-441000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021Q3 cybe Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
3 stock-based_complensation_plan
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
419100 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.22
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
77125 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1775 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
17.52
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
340200 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.10
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
216901 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
cybe Share Based Compensation Arrangement By Share Based Payment Award Options Grants Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsForfeituresAndExpirationsInPeriod
0 shares
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
2500000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
199000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
179000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
68454 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
21.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
8000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
6000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
28.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
850 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
21.92
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
69604 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
21.61
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
327000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
999000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
305000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
863000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2000000.0 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M14D
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
70591000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
226000 USD
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
727000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
327000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
247000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
4798000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
75278000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
65528000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
292000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
727000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
999000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
247000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-409000 USD
us-gaap Net Income Loss
NetIncomeLoss
9348000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
75278000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
60955000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
66000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
305000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
224000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
190000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
63539000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
58324000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
322000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
420000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
863000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
224000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-50000 USD
us-gaap Net Income Loss
NetIncomeLoss
4276000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
63539000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
15174000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2459000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2323000 USD
CY2021Q3 us-gaap Other Inventory Demo
OtherInventoryDemo
1448000 USD
CY2020Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
1701000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
20677000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
20271000 USD
cybe Demonstration Inventory Useful Life
DemonstrationInventoryUsefulLife
P36M
CY2021Q3 cybe Accumulated Amortization Inventories
AccumulatedAmortizationInventories
2700000 USD
CY2020Q4 cybe Accumulated Amortization Inventories
AccumulatedAmortizationInventories
2700000 USD
CY2021Q3 cybe Amortization Expense Related To Demonstration Inventories
AmortizationExpenseRelatedToDemonstrationInventories
175000 USD
cybe Amortization Expense Related To Demonstration Inventories
AmortizationExpenseRelatedToDemonstrationInventories
498000 USD
CY2020Q3 cybe Amortization Expense Related To Demonstration Inventories
AmortizationExpenseRelatedToDemonstrationInventories
171000 USD
cybe Amortization Expense Related To Demonstration Inventories
AmortizationExpenseRelatedToDemonstrationInventories
613000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3034000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2768000 USD
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
943000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
793000 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
263000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
269000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
113000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4353000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3893000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
839000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
798000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
814000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
726000 USD
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-54000 USD
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-21000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
599000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
683000 USD
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1000000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
820000 USD
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
943000 USD
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
784000 USD
CY2021Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
57000 USD
us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
417000 USD
CY2019Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
275000 USD
us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
382000 USD
cybe Extended Product Warranty Accrual Amortization Of Deferred Revenue
ExtendedProductWarrantyAccrualAmortizationOfDeferredRevenue
348000 USD
cybe Extended Product Warranty Accrual Amortization Of Deferred Revenue
ExtendedProductWarrantyAccrualAmortizationOfDeferredRevenue
269000 USD
CY2021Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
413000 USD
CY2020Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
388000 USD
CY2021Q3 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
298000 USD
CY2020Q3 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
274000 USD
CY2021Q3 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
115000 USD
CY2020Q3 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
114000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2333000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1952000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2139000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1814000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
325000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
52000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
149000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
140000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
51000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
174000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
126000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
30000 USD
CY2020Q3 us-gaap Revenues
Revenues
20820000 USD
us-gaap Revenues
Revenues
70698000 USD
us-gaap Revenues
Revenues
53245000 USD
CY2021Q3 cybe Revenue Export Sales Percentage
RevenueExportSalesPercentage
0.88 pure
cybe Revenue Export Sales Percentage
RevenueExportSalesPercentage
0.85 pure
CY2020Q3 cybe Revenue Export Sales Percentage
RevenueExportSalesPercentage
0.84 pure
cybe Revenue Export Sales Percentage
RevenueExportSalesPercentage
0.80 pure
CY2021Q3 cybe Export Revenues
ExportRevenues
24409000 USD
CY2020Q3 cybe Export Revenues
ExportRevenues
17540000 USD
cybe Export Revenues
ExportRevenues
60091000 USD
cybe Export Revenues
ExportRevenues
42694000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
47000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
4798000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7324000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
256000 shares
CY2021Q3 cybe Earnings Per Share Dilutive Adjustment
EarningsPerShareDilutiveAdjustment
-0.03
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
4798000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7580000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1799000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7240000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
279000 shares
CY2020Q3 cybe Earnings Per Share Dilutive Adjustment
EarningsPerShareDilutiveAdjustment
-0.01
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1799000 USD
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7519000 shares
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Net Income Loss
NetIncomeLoss
9348000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7305000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
215000 shares
cybe Earnings Per Share Dilutive Adjustment
EarningsPerShareDilutiveAdjustment
-0.04
us-gaap Net Income Loss
NetIncomeLoss
9348000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7520000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
us-gaap Net Income Loss
NetIncomeLoss
4276000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
247000 shares
cybe Earnings Per Share Dilutive Adjustment
EarningsPerShareDilutiveAdjustment
-0.02
us-gaap Net Income Loss
NetIncomeLoss
4276000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63000 shares
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-159000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-159000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
236000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
236000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-6000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-25000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-58000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-12000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-46000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-6000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-184000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
178000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
203000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-12000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
190000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-285000 USD
us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-285000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-210000 USD
us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-210000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-156000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-32000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-124000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
43000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
160000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-32000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-409000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-7000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
43000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-50000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1102000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-409000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1511000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1406000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-50000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1456000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
514000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
409000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
462000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.13 pure
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10 pure
CY2021Q3 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-412000 USD
us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-414000 USD
CY2020Q3 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-11000 USD
us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
-367000 USD
cybe Need For Valuation Allowance Based On History Of Cumulative Losses
NeedForValuationAllowanceBasedOnHistoryOfCumulativeLosses
P3Y

Files In Submission

Name View Source Status
0000897101-21-000885-index-headers.html Edgar Link pending
0000897101-21-000885-index.html Edgar Link pending
0000897101-21-000885.txt Edgar Link pending
0000897101-21-000885-xbrl.zip Edgar Link pending
cybe-20210930.htm Edgar Link pending
cybe-20210930.xsd Edgar Link pending
cybe-20210930_cal.xml Edgar Link unprocessable
cybe-20210930_def.xml Edgar Link unprocessable
cybe-20210930_htm.xml Edgar Link completed
cybe-20210930_lab.xml Edgar Link unprocessable
cybe-20210930_pre.xml Edgar Link unprocessable
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex32_3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending